002007.SZ SHZ
Hualan Biological Engineering Inc.
1W: +0.5%
1M: +2.0%
3M: +4.7%
YTD: -14.3%
1Y: -17.2%
3Y: -35.9%
5Y: -61.1%
¥13.34 ($1.99)
+0.32 (+2.46%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.1B
+7.8% ▲
5Y CAGR: -2.9%
Capital Expenditures
$197M
+22.9% ▲
5Y CAGR: -20.5%
Free Cash Flow
$945M
+17.5% ▲
5Y CAGR: +6.1%
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$592M
-260.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.5B | $1.2B | $1.8B | $1.2B | $940M |
| Depreciation & Amort. | $196M | $273M | $274M | $261M | $282M |
| Stock-Based Comp. | $3M | $29M | $35M | $0 | $0 |
| Change in Working Capital | -$301M | -$614M | -$576M | -$297M | -$435M |
| Other Non-Cash Items | $89M | $67M | -$161M | -$61M | $349M |
| Operating Cash Flow | $1.4B | $957M | $1.3B | $1.1B | $1.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$811M | -$394M | -$753M | -$255M | -$197M |
| Acquisitions (Net) | $909K | $2.3B | $0 | $2M | $3M |
| Investment Purchases | -$14.5B | -$12.7B | -$6.9B | -$23.4B | -$11.8B |
| Investment Sales | $13.5B | $10.6B | $6.5B | $23.8B | $12.2B |
| Other Investing | $0 | -$2.3B | $164M | -$362K | $0 |
| Investing Cash Flow | -$1.8B | -$2.5B | -$1.0B | $90M | $270M |
| — Financing Activities — | |||||
| Net Debt Issuance | $600M | $100M | $100M | -$104M | -$454M |
| Stock Repurchased | $0 | $0 | $0 | -$107M | $0 |
| Dividends Paid | -$547M | -$365M | -$564M | -$468M | $0 |
| Other Financing | $0 | -$61M | $9M | -$102M | -$1.5B |
| Financing Cash Flow | $36M | $1.9B | -$455M | -$780M | -$2.0B |
| Net Change in Cash | -$290M | $425M | -$107M | $369M | -$592M |
| Cash End of Period | $671M | $1.1B | $989M | $1.4B | $775M |
| Free Cash Flow | $621M | $563M | $592M | $804M | $945M |